Commercialization

The translational pathway from the laboratory to the patient presents an ideal opportunity for the Foundation to convene interested parties representing academic research institutions, intellectual property firms, regulatory and reimbursement agencies, companies already underway with clinical trials and good manufacturing practice (GMP) facilities, as well as entrepreneurs and investors involved in launching new ventures.

Regulatory

The Foundation believes the regulatory process is invaluable in the development of safe and effective therapies for patients. Education and balanced discourse will ultimately serve to advance regenerative medicine within the regulatory framework, and the Foundation will take a lead role in those efforts. As the pace quickens for new developments in regenerative medicine, as well as in biomaterials and enabling technologies, regulators, researchers and industry executives will benefit from Foundation-hosted forums designed to create innovative, positive outcomes while avoiding detrimental impact for patients and healthcare providers.

Conferences and Meetings

As its main educational event, the Regenerative Medicine Foundation produces an annual Regenerative Medicine Translational Forum focusing on the entire continuum from laboratory research to patient care and quality of life. Additionally, the Foundation will host topic-specific forums throughout the year in Winston-Salem, NC, Washington DC and other locations. Topics will include but are not limited to: stem cell sources, biomaterials and enabling technologies, best practices in clinical trials and GMP facilities, regulatory and reimbursement opportunities and healthcare reform.